跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oframac - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Oframac
Approved
STANDARD
Oframac
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b4bf62213a46cda3
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
b4bf62213a46cda3
Drug Approval Philippines Name
Oframac
Product Name
Oframac
Registration Number
DR-XY31432
Brand Name
Oframac
Generic Name
Ofloxacin
Dosage Form
Film-Coated Tablet
Dosage Strength
400 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Euro-Health Care Exponents, Inc.
Distributor
TGP PHARMA, INC.
Issuance Date
27 November 2020
Expiry Date
18 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b4bf62213a46cda3
Type
Standard
Back to Philippines FDA Approvals